<p>Braidwell LP 在第二季度收购了 Globus Medical, Inc.（纽约证券交易所代码：GMED - 免费报告）的一项新头寸，根据该公司在最近向证券交易委员会的披露。该公司收购了 247,200 股医疗设备公司的股票，价值约为 14,590,000 美元。截至最近的 SEC 备案，Braidwell LP 持有 Globus Medical 的 0.18%。</p>
<p>获取 <strong>Globus Medical</strong> 的提醒：</p>
<p>其他对冲基金最近也对该公司的头寸进行了调整。Brevan Howard Capital Management LP 在第二季度购买了 Globus Medical 的新股份，价值约为 547,000 美元。Blue Capital Inc.在第二季度购买了 Globus Medical 的股份，价值为 443,000 美元。Ameriprise Financial Inc.在第二季度将其在 Globus Medical 的股份提高了 24.3%。Ameriprise Financial Inc.现在拥有 205,173 股医疗设备公司的股票，价值为 12,109,000 美元，此前在该期间内又购买了 40,090 股。AQR Capital Management LLC 在第二季度将其在 Globus Medical 的股份提高了 397.6%。AQR Capital Management LLC 现在拥有 112,001 股医疗设备公司的股票，价值为 6,595,000 美元，此前在该期间内又购买了 89,491 股。最后，Quantinno Capital Management LP 在第二季度将其在 Globus Medical 的股份提高了 79.4%。Quantinno Capital Management LP 现在拥有 13,450 股医疗设备公司的股票，价值为 794,000 美元，此前在上个季度又购买了 5,952 股。目前，95.16% 的股票由机构投资者持有。</p>
<h2>内部人士下注</h2>
<p>在其他 Globus Medical 的新闻中，董事 Stephen T. Zarrilli 在 11 月 11 日星期二出售了 25,000 股公司的股票。股票以平均价格 84.29 美元出售，总交易额为 2,107,250.00 美元。此次出售在与 SEC 的法律文件中披露，可以通过此超链接访问。此外，SVP Kelly Huller 在 11 月 25 日星期二出售了 7,500 股公司的股票。股票以平均价格 90.00 美元出售，总价值为 675,000.00 美元。此次出售的披露在 SEC 备案中可用。在过去的九十天里，内部人士出售了 96,042 股公司股票，价值为 8,003,630 美元。内部人士持有公司股票的 18.51%。</p>
<h2>分析师升级和降级</h2>
<p>多家券商对 GMED 发布了报告。Stifel Nicolaus 在 10 月 28 日星期二的研究报告中开始覆盖 Globus Medical。他们对该公司发布了 “持有” 评级，并设定了 64.00 美元的目标价。Wells Fargo &amp; Company 在 11 月 7 日星期五的研究报告中将 Globus Medical 的目标价从 66.00 美元上调至 79.00 美元，并给予该股票 “增持” 评级。Zacks Research 在星期二的研究报告中将 Globus Medical 的评级从 “强力买入” 下调至 “持有”。Truist Financial 在 11 月 18 日星期二的报告中重新发布了 “买入” 评级，并对 Globus Medical 的股票设定了 105.00 美元的目标价（上调自 93.00 美元）。最后，Barclays 在 11 月 10 日星期一的研究报告中将 Globus Medical 的目标价从 106.00 美元上调至 114.00 美元，并给予该股票 “增持” 评级。九位投资分析师对该股票给予了买入评级，六位对公司的股票给予了持有评级。根据 MarketBeat 的数据，Globus Medical 的共识评级为 “适度买入”，平均目标价为 93.00 美元。</p>
<p><strong>查看我们对 GMED 的最新分析</strong></p>
<h2>Globus Medical 股价下跌 2.4%</h2>
<p>GMED 股票在星期五开盘价为 86.77 美元。该股票的市值为 116.1 亿美元，市盈率为 27.99，市盈率增长比率为 1.64，贝塔值为 1.07。Globus Medical, Inc.的 12 个月低点为 51.79 美元，12 个月高点为 94.93 美元。该股票的 50 日移动平均价格为 74.46 美元，200 日移动平均价格为 63.77 美元。</p>
<p>Globus Medical（纽约证券交易所代码：GMED - 获取免费报告）最后一次公布季度财报是在 11 月 6 日星期四。该医疗设备公司报告本季度每股收益为 1.18 美元，超出分析师共识预期的 0.79 美元，超出幅度为 0.39 美元。Globus Medical 的股本回报率为 11.52%，净利润率为 15.30%。该公司在本季度的收入为 769.05 百万美元，而分析师预期为 734.58 百万美元。在去年同期，该公司每股收益为 0.83 美元。该公司的收入同比增长 22.9%。Globus Medical 已将其 2025 财年的指导目标设定为 3.750-3.85 每股收益。整体而言，研究分析师预测 Globus Medical, Inc.在当前财年将发布 3.44 每股收益。</p>
<h2>关于 Globus Medical</h2>
<p>（免费报告）</p>
<p>Globus Medical, Inc.是一家医疗设备公司，开发和商业化针对美国及国际上肌肉骨骼疾病患者的医疗解决方案。该公司提供脊柱产品，如传统融合植入物，包括椎弓根螺钉和杆系统、板系统、椎间隔器和用于治疗退行性和先天性疾病、畸形、肿瘤和创伤性损伤的椎体切除装置；运动保留技术的治疗选项，包括动态稳定、全椎间盘置换和椎间分离装置；治疗椎体压缩骨折的介入解决方案；以及包括同种异体移植物和合成替代品的再生生物产品。</p>
<h2>精选故事</h2>
<ul>
<li>五只我们更看好的股票超过 Globus Medical</li>
<li>如何捕捉股息增加的好处</li>
<li>Synopsys 因 Ansys 整合推动增长而出现看涨转变</li>
<li>上海证券交易所综合指数是什么？</li>
<li>你能给自己最好的节日礼物是什么？Costco 股票</li>
<li>三只值得购买和持有的医疗保健股息股票</li>
<li>为什么 Zscaler 股票在 30% 的抛售后可能准备反弹</li>
</ul>
<p><strong>想知道其他对 GMED 持有何种投资的对冲基金吗？</strong> 请访问 HoldingsChannel.com 获取 Globus Medical, Inc. (NYSE:GMED - 免费报告) 的最新 13F 文件和内部交易信息。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUdNRUQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUdNRUQ"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Globus Medical 吗？</h2>
<p>在考虑投资 Globus Medical 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐在更广泛市场注意到之前购买……而 Globus Medical 并不在名单上。</p>
<p>虽然 Globus Medical 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

Globus医疗

<p>Braidwell LP 在第二季度收购了 247,200 股 Globus Medical，价值 1459 万美元。其他对冲基金也调整了他们的持仓。内部人士出售了价值 800 万美元的股票。分析师的评级各不相同，普遍共识为 “适度买入”，平均目标价为 93 美元。Globus Medical 的股票开盘价为 86.77 美元，市值为 116.1 亿美元。该公司报告了强劲的季度收益，超出预期，每股收益为 1.18 美元，收入为 7.6905 亿美元，同比增长 22.9%</p>

<p>Braidwell LP acquired a new position in Globus Medical, Inc. (NYSE:GMED - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities &amp; Exchange Commission. The firm acquired 247,200 shares of the medical device company's stock, valued at approximately $14,590,000. Braidwell LP owned 0.18% of Globus Medical as of its most recent SEC filing.</p>
<div class="lb-trans"><p>Braidwell LP 在第二季度收购了 Globus Medical, Inc.（纽约证券交易所代码：GMED - 免费报告）的一项新头寸，根据该公司在最近向证券交易委员会的披露。该公司收购了 247,200 股医疗设备公司的股票，价值约为 14,590,000 美元。截至最近的 SEC 备案，Braidwell LP 持有 Globus Medical 的 0.18%。</p>
</div><p>Get <strong>Globus Medical</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Globus Medical</strong> 的提醒：</p>
</div><p>Other hedge funds also recently made changes to their positions in the company. Brevan Howard Capital Management LP bought a new stake in Globus Medical during the 2nd quarter worth approximately $547,000. Blue Capital Inc. purchased a new stake in shares of Globus Medical in the second quarter worth $443,000. Ameriprise Financial Inc. raised its position in shares of Globus Medical by 24.3% during the 2nd quarter. Ameriprise Financial Inc. now owns 205,173 shares of the medical device company's stock valued at $12,109,000 after purchasing an additional 40,090 shares during the period. AQR Capital Management LLC raised its position in shares of Globus Medical by 397.6% during the 2nd quarter. AQR Capital Management LLC now owns 112,001 shares of the medical device company's stock valued at $6,595,000 after purchasing an additional 89,491 shares during the period. Finally, Quantinno Capital Management LP lifted its stake in shares of Globus Medical by 79.4% during the 2nd quarter. Quantinno Capital Management LP now owns 13,450 shares of the medical device company's stock valued at $794,000 after buying an additional 5,952 shares in the last quarter. 95.16% of the stock is currently owned by institutional investors.</p>
<div class="lb-trans"><p>其他对冲基金最近也对该公司的头寸进行了调整。Brevan Howard Capital Management LP 在第二季度购买了 Globus Medical 的新股份，价值约为 547,000 美元。Blue Capital Inc.在第二季度购买了 Globus Medical 的股份，价值为 443,000 美元。Ameriprise Financial Inc.在第二季度将其在 Globus Medical 的股份提高了 24.3%。Ameriprise Financial Inc.现在拥有 205,173 股医疗设备公司的股票，价值为 12,109,000 美元，此前在该期间内又购买了 40,090 股。AQR Capital Management LLC 在第二季度将其在 Globus Medical 的股份提高了 397.6%。AQR Capital Management LLC 现在拥有 112,001 股医疗设备公司的股票，价值为 6,595,000 美元，此前在该期间内又购买了 89,491 股。最后，Quantinno Capital Management LP 在第二季度将其在 Globus Medical 的股份提高了 79.4%。Quantinno Capital Management LP 现在拥有 13,450 股医疗设备公司的股票，价值为 794,000 美元，此前在上个季度又购买了 5,952 股。目前，95.16% 的股票由机构投资者持有。</p>
</div><h2>Insiders Place Their Bets</h2>
<div class="lb-trans"><h2>内部人士下注</h2>
</div><p>In other Globus Medical news, Director Stephen T. Zarrilli sold 25,000 shares of the business's stock in a transaction that occurred on Tuesday, November 11th. The stock was sold at an average price of $84.29, for a total transaction of $2,107,250.00. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, SVP Kelly Huller sold 7,500 shares of the company's stock in a transaction that occurred on Tuesday, November 25th. The shares were sold at an average price of $90.00, for a total value of $675,000.00. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 96,042 shares of company stock worth $8,003,630. Insiders own 18.51% of the company's stock.</p>
<div class="lb-trans"><p>在其他 Globus Medical 的新闻中，董事 Stephen T. Zarrilli 在 11 月 11 日星期二出售了 25,000 股公司的股票。股票以平均价格 84.29 美元出售，总交易额为 2,107,250.00 美元。此次出售在与 SEC 的法律文件中披露，可以通过此超链接访问。此外，SVP Kelly Huller 在 11 月 25 日星期二出售了 7,500 股公司的股票。股票以平均价格 90.00 美元出售，总价值为 675,000.00 美元。此次出售的披露在 SEC 备案中可用。在过去的九十天里，内部人士出售了 96,042 股公司股票，价值为 8,003,630 美元。内部人士持有公司股票的 18.51%。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析师升级和降级</h2>
</div><p>A number of brokerages have issued reports on GMED. Stifel Nicolaus started coverage on Globus Medical in a research note on Tuesday, October 28th. They issued a &#34;hold&#34; rating and a $64.00 price target for the company. Wells Fargo &amp; Company upped their price objective on Globus Medical from $66.00 to $79.00 and gave the stock an &#34;overweight&#34; rating in a research note on Friday, November 7th. Zacks Research downgraded Globus Medical from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a research note on Tuesday. Truist Financial reissued a &#34;buy&#34; rating and issued a $105.00 price target (up from $93.00) on shares of Globus Medical in a report on Tuesday, November 18th. Finally, Barclays upped their price target on Globus Medical from $106.00 to $114.00 and gave the stock an &#34;overweight&#34; rating in a research note on Monday, November 10th. Nine investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company's stock. According to data from MarketBeat, Globus Medical has a consensus rating of &#34;Moderate Buy&#34; and an average target price of $93.00.</p>
<div class="lb-trans"><p>多家券商对 GMED 发布了报告。Stifel Nicolaus 在 10 月 28 日星期二的研究报告中开始覆盖 Globus Medical。他们对该公司发布了 “持有” 评级，并设定了 64.00 美元的目标价。Wells Fargo &amp; Company 在 11 月 7 日星期五的研究报告中将 Globus Medical 的目标价从 66.00 美元上调至 79.00 美元，并给予该股票 “增持” 评级。Zacks Research 在星期二的研究报告中将 Globus Medical 的评级从 “强力买入” 下调至 “持有”。Truist Financial 在 11 月 18 日星期二的报告中重新发布了 “买入” 评级，并对 Globus Medical 的股票设定了 105.00 美元的目标价（上调自 93.00 美元）。最后，Barclays 在 11 月 10 日星期一的研究报告中将 Globus Medical 的目标价从 106.00 美元上调至 114.00 美元，并给予该股票 “增持” 评级。九位投资分析师对该股票给予了买入评级，六位对公司的股票给予了持有评级。根据 MarketBeat 的数据，Globus Medical 的共识评级为 “适度买入”，平均目标价为 93.00 美元。</p>
</div><p><strong>View Our Latest Analysis on GMED</strong></p>
<div class="lb-trans"><p><strong>查看我们对 GMED 的最新分析</strong></p>
</div><h2>Globus Medical Trading Down 2.4%</h2>
<div class="lb-trans"><h2>Globus Medical 股价下跌 2.4%</h2>
</div><p>Shares of GMED stock opened at $86.77 on Friday. The stock has a market capitalization of $11.61 billion, a price-to-earnings ratio of 27.99, a price-to-earnings-growth ratio of 1.64 and a beta of 1.07. Globus Medical, Inc. has a 12-month low of $51.79 and a 12-month high of $94.93. The stock's 50-day moving average price is $74.46 and its 200-day moving average price is $63.77.</p>
<div class="lb-trans"><p>GMED 股票在星期五开盘价为 86.77 美元。该股票的市值为 116.1 亿美元，市盈率为 27.99，市盈率增长比率为 1.64，贝塔值为 1.07。Globus Medical, Inc.的 12 个月低点为 51.79 美元，12 个月高点为 94.93 美元。该股票的 50 日移动平均价格为 74.46 美元，200 日移动平均价格为 63.77 美元。</p>
</div><p>Globus Medical (NYSE:GMED - Get Free Report) last announced its quarterly earnings results on Thursday, November 6th. The medical device company reported $1.18 EPS for the quarter, beating analysts' consensus estimates of $0.79 by $0.39. Globus Medical had a return on equity of 11.52% and a net margin of 15.30%.The company had revenue of $769.05 million during the quarter, compared to analyst estimates of $734.58 million. During the same period in the prior year, the company earned $0.83 earnings per share. The firm's revenue was up 22.9% on a year-over-year basis. Globus Medical has set its FY 2025 guidance at 3.750-3.85 EPS. As a group, research analysts predict that Globus Medical, Inc. will post 3.44 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>Globus Medical（纽约证券交易所代码：GMED - 获取免费报告）最后一次公布季度财报是在 11 月 6 日星期四。该医疗设备公司报告本季度每股收益为 1.18 美元，超出分析师共识预期的 0.79 美元，超出幅度为 0.39 美元。Globus Medical 的股本回报率为 11.52%，净利润率为 15.30%。该公司在本季度的收入为 769.05 百万美元，而分析师预期为 734.58 百万美元。在去年同期，该公司每股收益为 0.83 美元。该公司的收入同比增长 22.9%。Globus Medical 已将其 2025 财年的指导目标设定为 3.750-3.85 每股收益。整体而言，研究分析师预测 Globus Medical, Inc.在当前财年将发布 3.44 每股收益。</p>
</div><h2>About Globus Medical</h2>
<div class="lb-trans"><h2>关于 Globus Medical</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Globus Medical, Inc, a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives.</p>
<div class="lb-trans"><p>Globus Medical, Inc.是一家医疗设备公司，开发和商业化针对美国及国际上肌肉骨骼疾病患者的医疗解决方案。该公司提供脊柱产品，如传统融合植入物，包括椎弓根螺钉和杆系统、板系统、椎间隔器和用于治疗退行性和先天性疾病、畸形、肿瘤和创伤性损伤的椎体切除装置；运动保留技术的治疗选项，包括动态稳定、全椎间盘置换和椎间分离装置；治疗椎体压缩骨折的介入解决方案；以及包括同种异体移植物和合成替代品的再生生物产品。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精选故事</h2>
</div><ul>
<li>Five stocks we like better than Globus Medical</li>
<li>How to Capture the Benefits of Dividend Increases</li>
<li>Synopsys Sees Bullish Shift as Ansys Integration Drives Growth</li>
<li>What is the Shanghai Stock Exchange Composite Index?</li>
<li>The Best Holiday Present You Can Give Yourself? Costco Stock</li>
<li>The Top 3 Healthcare Dividend Stocks to Buy and Hold</li>
<li>Why Zscaler Stock Could Be Ready to Bounce After a 30% Selloff</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票超过 Globus Medical</li>
<li>如何捕捉股息增加的好处</li>
<li>Synopsys 因 Ansys 整合推动增长而出现看涨转变</li>
<li>上海证券交易所综合指数是什么？</li>
<li>你能给自己最好的节日礼物是什么？Costco 股票</li>
<li>三只值得购买和持有的医疗保健股息股票</li>
<li>为什么 Zscaler 股票在 30% 的抛售后可能准备反弹</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding GMED?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Globus Medical, Inc. (NYSE:GMED - Free Report).</p>
<div class="lb-trans"><p><strong>想知道其他对 GMED 持有何种投资的对冲基金吗？</strong> 请访问 HoldingsChannel.com 获取 Globus Medical, Inc. (NYSE:GMED - 免费报告) 的最新 13F 文件和内部交易信息。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUdNRUQ" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=GMED"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Globus Medical Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Globus Medical 吗？</h2>
</div><p>Before you consider Globus Medical, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑投资 Globus Medical 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Globus Medical wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐在更广泛市场注意到之前购买……而 Globus Medical 并不在名单上。</p>
</div><p>While Globus Medical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Globus Medical 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Braidwell LP 购买了 247,200 股 Globus 医疗公司的股票，代码为$GMED